- Home
- IOVA vs QCRH Comparison
IOVA vs QCRH Comparison
Compare IOVA & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- QCRH
- Stock Information
- Founded
- IOVA 2007
- QCRH 1993
- Country
- IOVA United States
- QCRH United States
- Employees
- IOVA N/A
- QCRH N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- QCRH Major Banks
- Sector
- IOVA Health Care
- QCRH Finance
- Exchange
- IOVA Nasdaq
- QCRH Nasdaq
- Market Cap
- IOVA 1.0B
- QCRH 1.1B
- IPO Year
- IOVA N/A
- QCRH 1993
- Fundamental
- Price
- IOVA $1.75
- QCRH $67.06
- Analyst Decision
- IOVA Strong Buy
- QCRH Buy
- Analyst Count
- IOVA 9
- QCRH 3
- Target Price
- IOVA $15.50
- QCRH $86.67
- AVG Volume (30 Days)
- IOVA 13.9M
- QCRH 91.1K
- Earning Date
- IOVA 05-08-2025
- QCRH 04-22-2025
- Dividend Yield
- IOVA N/A
- QCRH 0.36%
- EPS Growth
- IOVA N/A
- QCRH N/A
- EPS
- IOVA N/A
- QCRH 6.65
- Revenue
- IOVA $212,679,000.00
- QCRH $324,275,000.00
- Revenue This Year
- IOVA $182.20
- QCRH N/A
- Revenue Next Year
- IOVA $62.10
- QCRH $15.85
- P/E Ratio
- IOVA N/A
- QCRH $10.01
- Revenue Growth
- IOVA 11070.12
- QCRH N/A
- 52 Week Low
- IOVA $2.70
- QCRH $54.75
- 52 Week High
- IOVA $13.60
- QCRH $96.08
- Technical
- Relative Strength Index (RSI)
- IOVA 23.78
- QCRH 50.57
- Support Level
- IOVA $3.02
- QCRH $64.64
- Resistance Level
- IOVA $3.31
- QCRH $67.00
- Average True Range (ATR)
- IOVA 0.24
- QCRH 1.82
- MACD
- IOVA -0.09
- QCRH 0.48
- Stochastic Oscillator
- IOVA 4.81
- QCRH 49.42
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About QCRH QCR Holdings Inc.
QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely QCBT, CRBT, CSB, and GB. It generates revenue in the form of interest.